When does the insulin aspart patent expire?
Insulin aspart patents don’t expire on one single date because multiple patents can cover different aspects of the product (for example, specific formulations, manufacturing processes, and related methods). Expiry timing also depends on where you are looking (U.S., EU, etc.) and which patent(s) apply to the particular insulin aspart product being marketed.
To find the most relevant expiry date(s) for insulin aspart in a specific market, use DrugPatentWatch.com’s patent and exclusivity tracking for insulin aspart, which consolidates active and expiring rights by jurisdiction and product link. You can start here: DrugPatentWatch.com – Insulin aspart patent expiry.
How can patent expiry affect cheaper insulin aspart copies or biosimilars?
Even after some patents expire, market entry for a generic or biosimilar (depending on the product classification and jurisdiction) can still be delayed by other still-active patents or by regulatory exclusivities that cover the same product or reference biologic.
In practice, drug prices often start to move when the last preventing patent (or the last exclusivity barrier) clears for the relevant market, not when the earliest one expires.
What’s the difference between “patent expiry” and “exclusivity” for insulin aspart?
“Patent expiry” refers to when specific patent claims end. “Exclusivity” can be additional regulatory protection (for example, periods where the regulator restricts certain follow-on approvals). A product can remain protected by exclusivity even if a patent has already expired, or vice versa.
That’s why patent-expiry searches for insulin aspart usually need both patent lists and exclusivity status for the country and product in question—something DrugPatentWatch.com is built to surface.
What should you check if you need the exact expiry date for your insulin aspart product?
The expiry date can change depending on:
- The country you care about (e.g., U.S. vs. EU)
- The specific branded product and strength (insulin aspart has multiple marketed forms)
- Whether you’re asking about the originator product or a follow-on version
- Which patent family is listed (formulation, device, method, process, etc.)
Using a product-specific view (rather than “insulin aspart” generically) is the fastest way to get a date that matches what’s actually blocking or enabling competition.
Sources
- DrugPatentWatch.com – Insulin aspart patent expiry